Neuropsychiatric symptoms in dementia Mental and Behavioural Disorders Unspecified dementia
Conditions
Interventions
18 care centres in Berlin will be randomised to the intervention or control conditions:
1. Intervention centres:
1.1. 20 hours of training for nursing staff on causes, symptomatology and treatment of
Sponsors
Federal Office of Administration (Bundesverwaltungsamt [BVA]) (Germany)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Both male and female dementia patients aged 60 or older who live in a nursing home
Exclusion criteria
Exclusion criteria: 1. Inability to give informed consent and absence of a caregiver holding power of attorney 2. Any of the following conditions as defined by ICD-10 criteria 2.1. Presence of substance abuse (F 10) 2.2. Schizophrenia and associated conditions (F20) 2.3. Bipolar disorder (F30,31)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Agitation as measured with the Cohen-Mansfield Agitation inventory (CMAI) 2. Depression as measured with the Dementia Mood Assessment Scale (DMAS) 3. Apathy as measured with the Apathy Evaluation Scale (AES) All primary outcomes are measured at baseline and at 12 months. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Psychotropic medication in defined daily dosages 2. Number of hospital admissions 3. Caregiver burden as measured with the Perceived Stress Scale (PSS) 4. Mortality All secondary outcomes are measured at baseline, months 3, 6, and 12, and mortality dates are ascertained retrospectively. | — |
Countries
Germany
Outcome results
None listed